BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32363998)

  • 1. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients.
    Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
    Perit Dial Int; 2021 Mar; 41(2):236-243. PubMed ID: 32363998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.
    Rhee CM; Molnar MZ; Lau WL; Ravel V; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Perit Dial Int; 2014; 34(7):732-48. PubMed ID: 24385335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study on the change trend of serum alkaline phosphatase and its possible influencing factors in peritoneal dialysis patients.
    Zhao W; Zhang S; Zhao HD
    Sci Rep; 2024 Jun; 14(1):13099. PubMed ID: 38849443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
    Liu Y; He Q
    Clin Lab; 2015; 61(7):839-43. PubMed ID: 26299086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012.
    Liu CT; Lin YC; Lin YC; Kao CC; Chen HH; Hsu CC; Wu MS
    Sci Rep; 2017 Feb; 7(1):33. PubMed ID: 28232731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
    Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of parathyroid hormone concentration in hemodialysis patients.
    Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Sumida K; Molnar MZ; Potukuchi PK; Thomas F; Lu JL; Obi Y; Rhee CM; Streja E; Yamagata K; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2018 Feb; 33(2):264-273. PubMed ID: 28064159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorus control in peritoneal dialysis patients.
    Yavuz A; Ersoy FF; Passadakis PS; Tam P; Evaggelos DM; Katopodis KP; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis GJ; Dombros NA; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis CP; Yavuz M; Tsakiris DJ; Dimitriades AC; Yilmaz ME; Gültekin M; Süleymanlar G; Oreopoulos DG
    Kidney Int Suppl; 2008 Apr; (108):S152-8. PubMed ID: 18379539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study.
    Hong YA; Kim JH; Kim YK; Chang YK; Park CW; Kim SY; Kim YS; Kang SW; Kim NH; Kim YL; Yang CW
    Korean J Intern Med; 2020 Jan; 35(1):160-170. PubMed ID: 31648433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?
    Weissheimer R; Bucharles SGE; Truyts CAM; Jorgetti V; Figueiredo AE; Barrett P; Olandoski M; Pecoits-Filho R; Moraes TP
    J Bras Nefrol; 2021; 43(2):173-181. PubMed ID: 33538758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients.
    Jeong S; Oh JM; Oh KH; Kim IW
    PLoS One; 2017; 12(2):e0170535. PubMed ID: 28152049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal or low initial PTH levels are not a predictor of morbidity/mortality in patients undergoing chronic peritoneal dialysis.
    Dimkovic NB; Bargman J; Vas S; Oreopoulos DG
    Perit Dial Int; 2002; 22(2):204-10. PubMed ID: 11990405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS.
    Nitta K; Bieber B; Karaboyas A; Johnson DW; Kanjanabuch T; Kim YL; Lambie M; Hartman J; Shen JI; Naljayan M; Pecoits-Filho R; Robinson BM; Pisoni RL; Perl J; Kawanishi H
    Perit Dial Int; 2024 Mar; ():8968608241235516. PubMed ID: 38501163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combining different calcium concentration dialysate on calcium balance in peritoneal dialysis patients.
    Zhao HP; Wu B; Lu LX; Qiao J; Wu XL; Wang M
    Chin Med J (Engl); 2012 Nov; 125(22):4009-13. PubMed ID: 23158134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.